Videos

Video of Tim Kearns explaining the new Konica Minolta Exa Enterprise imaging system released at RSNA 2024.

Enterprise imaging expands in smaller and midsized hospitals

Smaller health systems are increasingly moving into this realm. Tim Kearns, director of marketing and healthcare IT, Konica Minolta Imaging USA, explains the implications.

 

Nina Kottler, MD, Radiology Partners, offers overview of the U.S. AI regulatory landscape as government and radiologists work on ways to ensure artificial intelligence is not bias and works properly.

Overview of the regulatory landscape of AI in radiology

Nina Kottler, MD, associate CMO for clinical AI at Radiology Partners, explains the movement toward greater regulation of artificial intelligence and the need to test for bias. 

Jessica H. Porembka, MD, FSBI, associate professor, breast imaging division University of Texas Southwestern Medical Center, Dallas, and vice chair of strategy and quality, and quality assurance medical director, Parkland Radiology in Dallas, explains how an ultrasound-first strategy for noncalcified lesions in DBT proves cost-effective.

Ultrasound-first strategy for noncalcified lesions in DBT proves cost-effective

Jessica Porembka, MD, of the breast imaging division at University of Texas Southwestern Medical Center, said an ultrasound-first strategy for these lesions in DBT is cost-effective and improves efficiency. 

Melissa Davis, MD, MBA, Yale University, explains her research into private equity market penetration in radiology.

Concerns about private equity's growing influence in radiology

Melissa Davis, MD, vice chair of medical informatics and associate professor at Yale University’s Department of Radiology and Biomedical Imaging, shares her findings from research on private equity market penetration.

 

Jessica H. Porembka, MD, FSBI, associate professor, breast imaging division University of Texas Southwestern Medical Center, Dallas, and vice chair of strategy and quality, and quality assurance medical director, Parkland Radiology in Dallas, discusses what it means when a radiology report says a patient has an architectural distortion on their mammogram.

What patients need to know about architectural distortion on breast imaging

Radiologist Jessica Porembka, MD, FSBI, an associate professor with the breast imaging division at University of Texas Southwestern Medical Center, explains what it means when a mammography report says a patient has architectural distortion.
 

Video of Steve Rankin, chief strategy officer for Enlitic, explaining how AI can help standardize labeling of medical images.

AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Christoph Wald, MD, vice chair of the ACR Board, explains the new ACR Assess-AI national data registry tracks performance of clinical AI algorithms.

ACR Assess-AI national data registry tracks performance of clinical algorithms

Christoph Wald, MD, vice chair of the ACR Board of Chancellors, explains how the new Assess-AI National Radiology Data Registry is designed to help monitor accuracy and other metrics for radiology artificial intelligence.

 

RBMA President Peter Moffatt explains trends in radiology business management at RSNA 2024. Topics include integration with AI, the radiologist staffing shortage, reimbursement issues and what to expect in healthcare policy from the Trump administration. #RBMA #RSNA24

The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.